Novavax COVID-19 Vaccine Phase 3 Trial To Begin In U.S.
Novavax on Monday announced the start of the Phase 3 trial of its Covid-19 vaccine in the United States and Mexico. It is the fifth company to launch a large-scale trial of a coronavirus vaccine in the United States.